NCT03526419View on ClinicalTrials.gov

Exparel PK and Breast Milk Excretion

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Milk Expression, Breast
Interventions
DRUG

Bupivacaine liposome

blood and milk samples will be obtained from those subjects after TAP block

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03526419 - Exparel PK and Breast Milk Excretion | Biotech Hunter | Biotech Hunter